VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced that its MiniVec™ plasmid ...

Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in gene delivery technologies and CDMO services, ...

Roche’s Foundation Medicine has linked with Fulgent Genetics to offer a new diagnostic test that identifies a person’s ...

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

In the first quarter, we delivered revenue growth of 22% year-over-year. In addition to processing more data volume than ever, we also achieved adjusted gross margin of 75.4%, demonstrating the unique ...

A common recessive NDD caused by RNU2-2 mutations disrupts brain development and opens paths for diagnosis and therapy.

Over the past few decades, neuroscientists and medical researchers worldwide have been trying to leverage available health ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that its common stock will transition from trading on The Nasdaq ...

For years, India’s vast genetic diversity has been overlooked by researchers. Now, the GenomeIndia Project has collected over ...

Penn researchers are developing a blood test to predict kidney disease risk in Black Americans, who face disproportionately ...

Man fated to get Alzheimer’s may have been saved by his profession - Finding may lead to new treatments and preventive ...

Vitamin D supplementation has shown some promise in reducing risk for progression from prediabetes to T2D. This study ...